Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Global
  • Legal
  • News
  • Penny Stocks
  • Small Cap

Psyched: Three Noteworthy Psychedelics M&As, Colorado’s Regulations, Exclusive Financing & More

By Lara Goldstein
September 5, 10:07 AM
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

ATAI

Read More
2 minute read
  • Cannabis
  • Exclusives
  • Financing
  • Market-Moving Exclusives
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

EXCLUSIVE: Psychedelics Co. Closes $7.5M Financing – Here’s Its Secret To Raising Millions In A Tough Environment

By Javier Hasse
September 1, 12:19 PM
In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of wellness.

CSE:PSYC

Read More
3 minute read
  • Cannabis
  • Earnings
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More

By Lara Goldstein
May 15, 5:30 PM
Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths Ph.D. Professorship Fund.

ATAI

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Amanita Muscaria Mushrooms Are Taking The Lead In Markets As Research Ramps Up

By Lara Goldstein
May 4, 8:33 AM
Amanita Muscaria is the only kind of mushroom currently legal. As its health benefits are regularly being confirmed in studies, demand for related products is rapidly growing.

PLSH

Read More
2 minute read
  • Cannabis
  • Contracts
  • Global
  • Guidance
  • Management
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics
  • Startups
  • Top Stories

Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation

By Lara Goldstein
February 16, 2:52 PM
Delix Nabs 2 New Partners Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience. The goal is to expedite Delix's drug development pipeline.

PSYCF

Read More
4 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce

By Lara Goldstein
January 24, 3:05 PM
Health Canada Oks Clinical-Grade MDMA Export To UK Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less than 300 grams of proprietary MDMA LaNeo.

PSYCF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Retail Sales

Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States

By Lara Goldstein
November 3, 7:37 PM
Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd.

PSYCF

Read More
6 minute read
  • Cannabis
  • Exclusives
  • General
  • Health Care
  • Interview
  • Markets
  • Penny Stocks
  • Psychedelics

This Legal Psychoactive Mushroom Reduces Stress And Pain And Encourages Longevity, Expert Says

By Natan Ponieman
October 6, 10:20 AM
This article was originally published in December 2021. Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood.

HAVLF

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service